157 related articles for article (PubMed ID: 24923332)
1. Survivin inhibition via EZN-3042 in canine lymphoma and osteosarcoma.
Shoeneman JK; Ehrhart EJ; Charles JB; Thamm DH
Vet Comp Oncol; 2016 Jun; 14(2):e45-57. PubMed ID: 24923332
[TBL] [Abstract][Full Text] [Related]
2. Phase-I trial of survivin inhibition with EZN-3042 in dogs with spontaneous lymphoma.
Thamm DH; Joseph JK; Rose BJ; Meuten TK; Weishaar KM
BMC Vet Res; 2020 Mar; 16(1):97. PubMed ID: 32209084
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of survivin expression in untreated and relapsed canine lymphoma.
Rebhun RB; Lana SE; Ehrhart EJ; Charles JB; Thamm DH
J Vet Intern Med; 2008; 22(4):989-95. PubMed ID: 18647159
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide.
Sapra P; Wang M; Bandaru R; Zhao H; Greenberger LM; Horak ID
Nucleosides Nucleotides Nucleic Acids; 2010 Feb; 29(2):97-112. PubMed ID: 20391197
[TBL] [Abstract][Full Text] [Related]
5. Expression and function of survivin in canine osteosarcoma.
Shoeneman JK; Ehrhart EJ; Eickhoff JC; Charles JB; Powers BE; Thamm DH
Cancer Res; 2012 Jan; 72(1):249-59. PubMed ID: 22068035
[TBL] [Abstract][Full Text] [Related]
6. YM155 inhibits tumor growth and enhances chemosensitivity to cisplatin in osteosarcoma.
Gao JZ; Chen FH; Wang L; Wei H; Meng SL
Eur Rev Med Pharmacol Sci; 2015; 19(11):2062-9. PubMed ID: 26125270
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical investigation of cell cycle and apoptosis regulators (survivin, β-catenin, p53, caspase 3) in canine appendicular osteosarcoma.
Bongiovanni L; Mazzocchetti F; Malatesta D; Romanucci M; Ciccarelli A; Buracco P; De Maria R; Palmieri C; Martano M; Morello E; Maniscalco L; Della Salda L
BMC Vet Res; 2012 Jun; 8():78. PubMed ID: 22686277
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression in correlation with apoptotic activity in canine lymphomas.
Sokołowska J; Urbańska K
Pol J Vet Sci; 2017 Mar; 20(2):329-338. PubMed ID: 28865215
[TBL] [Abstract][Full Text] [Related]
9. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
Ong SM; Saeki K; Kok MK; Nakagawa T; Nishimura R
J Vet Med Sci; 2019 Aug; 81(8):1182-1190. PubMed ID: 31308291
[TBL] [Abstract][Full Text] [Related]
10. Effects of etoposide alone and in combination with piroxicam on canine osteosarcoma cell lines.
Ong SM; Saeki K; Tanaka Y; Nishimura R; Nakagawa T
Vet J; 2016 Dec; 218():51-59. PubMed ID: 27938709
[TBL] [Abstract][Full Text] [Related]
11. β-Catenin transcriptional activity is minimal in canine osteosarcoma and its targeted inhibition results in minimal changes to cell line behaviour.
Piskun CM; Stein TJ
Vet Comp Oncol; 2016 Jun; 14(2):e4-e16. PubMed ID: 24256430
[TBL] [Abstract][Full Text] [Related]
12. +Antisense oligonucleotide targeting survivin inhibits growth by inducing apoptosis in human osteosarcoma cells MG-63.
Wu YF; Liang XJ; Liu YY; Gong W; Liu JX; Wang XP; Zhuang ZQ; Guo Y; Shen HY
Neoplasma; 2010; 57(6):501-6. PubMed ID: 20845987
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of survivin influences the biological activities of canine histiocytic sarcoma cell lines.
Yamazaki H; Takagi S; Hoshino Y; Hosoya K; Okumura M
PLoS One; 2013; 8(11):e79810. PubMed ID: 24260303
[TBL] [Abstract][Full Text] [Related]
14. Expression of nociceptive ligands in canine osteosarcoma.
Shor S; Fadl-Alla BA; Pondenis HC; Zhang X; Wycislo KL; Lezmi S; Fan TM
J Vet Intern Med; 2015 Jan; 29(1):268-75. PubMed ID: 25572473
[TBL] [Abstract][Full Text] [Related]
15. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.
Duan DP; Dang XQ; Wang KZ; Wang YP; Zhang H; You WL
Oncol Rep; 2012 Nov; 28(5):1693-700. PubMed ID: 22922684
[TBL] [Abstract][Full Text] [Related]
16. Survivin expression in canine lymphomas in relation with proliferative markers.
Sokołowska J; Urbańska K; Giziński S; Wysocka A; Cywińska A; Lechowski R
Pol J Vet Sci; 2015; 18(1):113-22. PubMed ID: 25928918
[TBL] [Abstract][Full Text] [Related]
17. Effects of transplantation sites on tumour growth, pulmonary metastasis and ezrin expression of canine osteosarcoma cell lines in nude mice.
Jaroensong T; Endo Y; Lee SJ; Kamida A; Mochizuki M; Nishimura R; Sasaki N; Nakagawa T
Vet Comp Oncol; 2012 Dec; 10(4):274-82. PubMed ID: 22236104
[TBL] [Abstract][Full Text] [Related]
18. The 5-lipoxygenase inhibitor tepoxalin induces oxidative damage and altered PTEN status prior to apoptosis in canine osteosarcoma cell lines.
Loftus JP; Cavatorta D; Bushey JJ; Levine CB; Sevier CS; Wakshlag JJ
Vet Comp Oncol; 2016 Jun; 14(2):e17-30. PubMed ID: 24813477
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor in canine osteosarcoma: association with clinicopathological parameters and prognosis.
Selvarajah GT; Verheije MH; Kik M; Slob A; Rottier PJ; Mol JA; Kirpensteijn J
Vet J; 2012 Aug; 193(2):412-9. PubMed ID: 22436430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
